ONO 3708
Alternative Names: ONO-3708 (TXA2/PGH2 receptor antagonist)Latest Information Update: 01 Jun 2011
At a glance
- Originator Ono Pharmaceutical
- Class Antiasthmatics; Antiplatelets; Small molecules
- Mechanism of Action Prostaglandin receptor antagonists; Thromboxane A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Hypertension; Ischaemic heart disorders; Thrombosis
Most Recent Events
- 01 Jun 2011 Discontinued - Phase-II for Ischaemic heart disorders in Japan (unspecified route)
- 01 Jun 2011 Discontinued - Phase-II for Thrombosis in Japan (unspecified route)
- 01 Jun 2011 Discontinued for Asthma in Japan (unspecified route)